Antemortem Heparin in Organ Donation After Circulatory Death Determination: A Systematic Review of the Literature

Supplemental Digital Content is available in the text. Donation after circulatory death determination frequently involves antemortem heparin administration to mitigate peri-arrest microvascular thrombosis. We systematically reviewed the literature to: (1) describe heparin administration practices and (2) explore the effects on transplant outcomes. We searched MEDLINE and EMBASE for studies reporting donation after circulatory death determination heparin practices including use, dosage, and timing (objective 1). To explore associations between antemortem heparin and transplant outcomes (objective 2), we (1) summarized within-study comparisons and (2) used meta-regression analyses to examine associations between proportions of donors that received heparin and transplant outcomes. We assessed risk of bias using the Newcastle Ottawa Scale and applied the GRADE methodology to determine certainty in the evidence. For objective 1, among 55 eligible studies, 48 reported heparin administration to at least some donors (range: 15.8%–100%) at variable doses (up to 1000 units/kg) and times relative to withdrawal of life-sustaining therapy. For objective 2, 7 studies that directly compared liver transplants with and without antemortem heparin reported lower rates of primary nonfunction, hepatic artery thrombosis, graft failure at 5 y, or recipient mortality (low certainty of evidence). In contrast, meta-regression analysis of 32 liver transplant studies detected no associations between the proportion of donors that received heparin and rates of early allograft dysfunction, primary nonfunction, hepatic artery thrombosis, biliary ischemia, graft failure, retransplantation, or patient survival (very low certainty of evidence). In conclusion, antemortem heparin practices vary substantially with an uncertain effect on transplant outcomes. Given the controversies surrounding antemortem heparin, clinical trials may be warranted.

[1]  M. Meade,et al.  Variability in deceased donor care in Canada: a report of the Canada-DONATE cohort study , 2020, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[2]  J. Ijzermans,et al.  Donor hepatectomy time influences ischemia-reperfusion injury of the biliary tree in donation after circulatory death liver transplantation. , 2020, Surgery.

[3]  G. Isac,et al.  Donation after circulatory determination of death in western Canada: a multicentre study of donor characteristics and critical care practices , 2020, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[4]  J. Cifrián,et al.  Combined lung and liver procurement in controlled donation after circulatory death using normothermic abdominal perfusion. Initial experience in two Spanish centers , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  S. Pértega,et al.  Results in liver transplantation using grafts from donors after controlled circulatory death: A single‐center experience comparing donor grafts harvested after controlled circulatory death to those harvested after brain death , 2019, Clinical transplantation.

[6]  Lunxu Liu,et al.  The comparable efficacy of lung donation after circulatory death and brain death: a systematic review and meta-analysis. , 2019, Transplantation.

[7]  K. Noyes,et al.  Transplant Outcomes of Donation After Circulatory Death Livers Recovered With Versus Without Premortem Heparin Administration , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[8]  M. Nijsten,et al.  Transplantation of High-risk Donor Livers After Ex Situ Resuscitation and Assessment Using Combined Hypo- and Normothermic Machine Perfusion: A Prospective Clinical Trial. , 2019, Annals of surgery.

[9]  N. Chalasani,et al.  Expanding the Donor Pool With the Use of Extended Criteria Donation After Circulatory Death Livers , 2019, Liver Transplantation.

[10]  K. Noyes,et al.  Outcomes of DCD kidneys recovered for transplantation with versus without pre‐mortem heparin administration , 2019, Clinical transplantation.

[11]  J. Neuberger,et al.  Survival advantage for patients accepting the offer of a circulatory death liver transplant. , 2019, Journal of hepatology.

[12]  J. Pijoan,et al.  Favorable Outcomes After Liver Transplantation With Normothermic Regional Perfusion From Donors After Circulatory Death: A Single-center Experience , 2019, Transplantation.

[13]  M. Perera,et al.  Retrieval Practice or Overall Donor and Recipient Risk: What Impacts on Outcomes After Donation After Circulatory Death Liver Transplantation in the United Kingdom? , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  B. Ericzon,et al.  Simultaneous Pancreas-Kidney Transplant From Donors After Brain Death vs Donors After Circulatory Death: A Single-Center Follow-up Study Over 3 Decades. , 2019, Transplantation proceedings.

[15]  D. Vijayanand,et al.  Impact of Donor Hepatectomy Time During Organ Procurement in Donation After Circulatory Death Liver Transplantation: The United Kingdom Experience , 2019, Transplantation.

[16]  I. Al Hasan,et al.  Can we reduce ischemic cholangiopathy rates in donation after cardiac death liver transplantation after 10 years of practice? Canadian single-centre experience , 2019, Canadian journal of surgery. Journal canadien de chirurgie.

[17]  C. Benden,et al.  Lung Transplantation with Controlled Donation after Circulatory Death Donors , 2018, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[18]  S. McCluskey,et al.  Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation , 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  C. Fondevila,et al.  Heparin but not tissue plasminogen activator improves outcomes in donation after circulatory death liver transplantation in a porcine model , 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[20]  W. Chapman,et al.  The influence of functional warm ischemia time on DCD liver transplant recipients’ outcomes , 2017, Clinical transplantation.

[21]  P. V. D. van der Boog,et al.  Pancreas Transplantation With Grafts From Donors Deceased After Circulatory Death: 5 Years Single-Center Experience , 2017, Transplantation.

[22]  Adam M. Kressel,et al.  Safety and Outcomes in 100 Consecutive Donation After Circulatory Death Liver Transplants Using a Protocol That Includes Thrombolytic Therapy , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  J. Rubio,et al.  Validation of a new proposal to avoid donor resuscitation in controlled donation after circulatory death with normothermic regional perfusion. , 2017, Resuscitation.

[24]  C. Doig,et al.  Premortem Heparin Administration and Location of Withdrawal of Life-Sustaining Interventions in DCD: Lack of High-Quality Evidence Precludes Definitive Conclusions. , 2016, Transplantation.

[25]  C. Kubal,et al.  Optimization of Perioperative Conditions to Prevent Ischemic Cholangiopathy in Donation After Circulatory Death Donor Liver Transplantation , 2016, Transplantation.

[26]  H. Opdam,et al.  Organ Donation after Circulatory Death in a University Teaching Hospital , 2016, Anaesthesia and intensive care.

[27]  P. Macdonald,et al.  Donation After Circulatory Death for Liver Transplantation: A Meta-Analysis on the Location of Life Support Withdrawal Affecting Outcomes , 2016, Transplantation.

[28]  C. Dunham,et al.  Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy. , 2016, World journal of gastroenterology.

[29]  R. Porte,et al.  Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[30]  M. B. Allen,et al.  Donor Hemodynamics as a Predictor of Outcomes After Kidney Transplantation From Donors After Cardiac Death , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  Charles M. Miller,et al.  Impact of donor age in liver transplantation from donation after circulatory death donors: A decade of experience at Cleveland Clinic , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[32]  J. Fung,et al.  Enhancing kidney function with thrombolytic therapy following donation after cardiac death: a multicenter quasi‐blinded prospective randomized trial , 2015, Clinical transplantation.

[33]  L. Kamal,et al.  Outcomes of Kidney Transplant Recipients From Donation After Circulatory Death Donors Without Preagonal Heparin Administration. , 2015, Transplantation.

[34]  W. Chapman,et al.  Outcomes Using Grafts from Donors after Cardiac Death. , 2015, Journal of the American College of Surgeons.

[35]  Min Zhang,et al.  Donation after cardiac death liver transplantation: Graft quality evaluation based on pretransplant liver biopsy , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[36]  S. Keshavjee,et al.  Lung Transplantation With Donation After Circulatory Determination of Death Donors and the Impact of Ex Vivo Lung Perfusion , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[37]  R. Love,et al.  Donation after circulatory death: the current state and technical approaches to organ procurement , 2015, Current opinion in organ transplantation.

[38]  J. Reyes,et al.  Differential Rates of Ischemic Cholangiopathy and Graft Survival Associated With Induction Therapy in DCD Liver Transplantation , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[39]  G. Oniscu,et al.  In Situ Normothermic Regional Perfusion for Controlled Donation After Circulatory Death—The United Kingdom Experience , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[40]  Qiang Zhao,et al.  Liver transplantation using organs from deceased organ donors: a single organ transplant center experience. , 2014, Hepatobiliary & pancreatic diseases international : HBPD INT.

[41]  T. Gonwa,et al.  Inferior long‐term outcomes of liver‐kidney transplantation using donation after cardiac death donors: Single‐center and organ procurement and transplantation network analyses , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[42]  M. Meurisse,et al.  Donor age as a risk factor in donation after circulatory death liver transplantation in a controlled withdrawal protocol programme , 2014, The British journal of surgery.

[43]  M. Bacchetta,et al.  Lung Transplantation Using Allografts From Donation After Cardiac Death Donors , 2014 .

[44]  J. Praestgaard,et al.  Donor hemodynamic profile presages graft survival in donation after cardiac death liver transplantation , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[45]  P. Gow,et al.  Predictors of early graft loss in donation after circulatory death liver transplantation. , 2013 .

[46]  S. Halpern,et al.  An official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statement: ethical and policy considerations in organ donation after circulatory determi , 2013, American journal of respiratory and critical care medicine.

[47]  Stephen J. Gentles,et al.  The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses. , 2013, Journal of clinical epidemiology.

[48]  H. Trivedi,et al.  Outcome of renal transplantation from deceased donors after cardiac death: a single-center experience from a developing country. , 2013, Transplantation proceedings.

[49]  D. Hathaway,et al.  Liver transplant using donors after cardiac death: a single-center approach providing outcomes comparable to donation after brain death. , 2013, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[50]  B. Griffith,et al.  Ex Vivo Lung Evaluation of Prearrest Heparinization in Donation After Cardiac Death , 2013, Annals of surgery.

[51]  G. Dellgren,et al.  Heparin does not improve graft function in uncontrolled non-heart-beating lung donation: an experimental study in pigs. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[52]  Elie A Akl,et al.  GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. , 2013, Journal of clinical epidemiology.

[53]  G. Snell,et al.  Excellent Clinical Outcomes From a National Donation‐After‐Determination‐of‐Cardiac‐Death Lung Transplant Collaborative , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[54]  S. Fuggle,et al.  Pancreas Transplantation From Donors After Circulatory Death From the United Kingdom , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[55]  J. Nguyen,et al.  Asystole to cross‐clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors , 2012, Transplant international : official journal of the European Society for Organ Transplantation.

[56]  N. Biller-Andorno,et al.  Whose consent matters? Controlled donation after cardiac death and premortem organ-preserving measures. , 2012, Transplantation.

[57]  J. Squifflet,et al.  Results of kidney transplantation from controlled donors after cardio‐circulatory death: a single center experience , 2012, Transplant international : official journal of the European Society for Organ Transplantation.

[58]  R. Truog,et al.  Donation after Circulatory Determination of Death , 2011 .

[59]  H. Sollinger,et al.  Donation after cardiac death: a 29-year experience. , 2011, Surgery.

[60]  Johnny C. Hong,et al.  Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. , 2011, Archives of surgery.

[61]  Scott R. Johnson,et al.  Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[62]  S. Keshavjee,et al.  Organ donation after cardiac death: donor and recipient outcomes after the first three years of the Ontario experience , 2011, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[63]  R. Stratta,et al.  Lessons learned from a single center's experience with 134 donation after cardiac death donor kidney transplants. , 2011, Journal of the American College of Surgeons.

[64]  H. Sollinger,et al.  Biliary Complications After Liver Transplantation From Donation After Cardiac Death Donors: An Analysis of Risk Factors and Long-term Outcomes From a Single Center , 2011, Annals of surgery.

[65]  Howard Balshem,et al.  GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.

[66]  F. Nevens,et al.  LIVER TRANSPLANTATION FROM DONATION AFTER CARDIOCIRCULATORY DEATH (DCD) DONORS: BELGIAN EXPERIENCE 2003-2009 , 2011 .

[67]  P. Marotta,et al.  The clinical consequences of utilizing donation after cardiac death liver grafts into hepatitis C recipients , 2011, Hepatology international.

[68]  F. Aucejo,et al.  Use of Tissue Plasminogen Activator in Liver Transplantation from Donation After Cardiac Death Donors , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[69]  S. Sano,et al.  Post-mortem tissue-type plasminogen activator preserves graft function of hearts harvested from non-pre-treated non-heart-beating donors. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[70]  E. Verschuuren,et al.  The use of non-heart-beating lung donors category III can increase the donor pool. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[71]  S. Yamamoto,et al.  Liver Transplantation with Grafts from Controlled Donors after Cardiac Death: A 20‐Year Follow‐up at a Single Center , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[72]  O. Ciccarelli,et al.  Liver transplantation from donation after cardiac death donors: initial Belgian experience 2003–2007 , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[73]  J. Feinglass,et al.  The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. , 2009, Surgery.

[74]  A. Demetris,et al.  Liver Transplantation Using Donation After Cardiac Death Donors: Long‐Term Follow‐Up from a Single Center , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[75]  J. Herget,et al.  Pre-arrest administration of the cell-permeable free radical scavenger tempol reduces warm ischemic damage of lung function in non-heart-beating donors. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[76]  J. Reyes,et al.  Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[77]  Anurag Maheshwari,et al.  Biliary complications and outcomes of liver transplantation from donors after cardiac death , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[78]  Y. Becker,et al.  Donation After Cardiac Death: The University of Wisconsin Experience With Liver Transplantation , 2005, Annals of surgery.

[79]  E. D. Motta The ethics of heparin administration to the potential non-heart-beating organ donor. , 2005, Journal of professional nursing : official journal of the American Association of Colleges of Nursing.

[80]  N. Polissar,et al.  Livers transplanted from donors after cardiac death occurring in the ICU or the operating room have excellent outcomes. , 2005, Transplantation proceedings.

[81]  N. Soomro,et al.  Do tissue damage biomarkers used to assess machine-perfused NHBD kidneys predict long-term renal function post-transplant? , 2003, Clinica chimica acta; international journal of clinical chemistry.

[82]  K. Olthoff,et al.  Liver transplantation from controlled non–heart-beating donors: an increased incidence of biliary complications , 2003, Transplantation.

[83]  P. Muiesan Liver Transplantation From Controlled Non???Heart-Beating Donors: An Increased Incidence of Biliary Complications. , 2003 .

[84]  H. Schäfers,et al.  Heparin and the nonanticoagulant N-acetyl heparin attenuate capillary no-reflow after normothermic ischemia of the lung. , 2001, The Annals of thoracic surgery.

[85]  S. Fujimi,et al.  Multivariate analyses of factors contributing to early graft function in 759 kidney transplants from non-heart-beating donors. , 2001, Transplantation proceedings.

[86]  C. Smee,et al.  United Kingdom , 2000, International Journal of Pharmaceutical Medicine.

[87]  M. Menger,et al.  Heparin and phentolamine combined, rather than heparin alone, improves hepatic microvascular procurement in a non‐heart‐beating donor rat‐model , 2000, Transplant international : official journal of the European Society for Organ Transplantation.

[88]  M. Morandini,et al.  Pre-arrest heparinization and ventilation during warm ischemia preserves lung function in non-heart-beating donors. , 1999, Journal of pediatric surgery.

[89]  T. Starzl,et al.  Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience. , 1995, Transplantation proceedings.

[90]  M. Shinoda,et al.  Clinical application of in situ renal cooling: experience with 61 cardiac-arrest donors. , 1989, Transplantation proceedings.

[91]  David A. Beety The United Kingdom Experience , 1977, Air and Space Law.

[92]  F. D'Ovidio,et al.  Use of Lung Allografts From Donation After Cardiac Death Donors: A Single-Center Experience. , 2018, The Annals of thoracic surgery.

[93]  A. Webster,et al.  Outcomes From Pancreatic Transplantation in Donation After Cardiac Death: A Systematic Review and Meta-Analysis , 2017, Transplantation.

[94]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[95]  E. Young The anti-inflammatory effects of heparin and related compounds. , 2008, Thrombosis research.

[96]  G. Knoll,et al.  National recommendations for donation after cardiocirculatory death in Canada: Donation after cardiocirculatory death in Canada. , 2006, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.